FILGOTINIB PROVIDED RAPID AND SUSTAINED RELIEF OF PAIN AND FATIGUE AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DMARDS: RESULTS FROM THE FINCH 2 STUDY

被引：0
|
作者：
Walker, D. [1 ]
Takeuchi, T. [2 ]
Bartok, B. [3 ]
Rao, S. [3 ]
Lee, I. H. [3 ]
Besuyen, R. [4 ]
Gottenberg, J. E. [5 ]
Genovese, M. C. [6 ]
机构：
[1] Northumbria Healthcare Trust, North Shields, England
[2] Keio Univ, Sch Med, Tokyo, Japan
[3] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[4] Galapagos BV, Leiden, Netherlands
[5] Strasbourg Univ Hosp, Strasbourg, France
[6] Stanford Univ, Stanford, CA 94305 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.2901
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0139
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [1] Filgotinib provided rapid and sustained relief of pain and fatigue and improved health-related quality of life in patients with rheumatoid arthritis and inadequate response to biologic DMARDs: Results from the FINCH 2 study
    Westhovens, R.
    Walker, D.
    Takeuchi, T.
    Bartok, B.
    Rao, S.
    Lee, I-H
    Besuyen, R.
    Gottenberg, J-E
    Genovese, M. C.
    SWISS MEDICAL WEEKLY, 2020, : 10S - 10S
  • [2] Filgotinib Provided Rapid and Sustained Relief of Pain and Fatigue and Improved Health-Related Quality of Life in Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs
    Walker, David
    Takeuchi, Tsutomu
    Bartok, Beatrix
    Rao, Shangbang
    Lee, I-Heng
    Besuyen, Robin
    Gottenberg, Jacques-Eric
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, HEALTH-RELATED QUALITY OF LIFE, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE FINCH 1 STUDY
    Kivitz, A.
    Tanaka, Y.
    Lee, S.
    Ye, L.
    Hu, H.
    Besuyen, R.
    Combe, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 641 - 642
  • [4] Filgotinib Provided Rapid and Sustained Improvements in Functional Status, Pain, Health-related Quality of Life, and Fatigue in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Kivitz, Alan
    Tanaka, Yoshiya
    Lee, Susan
    Ye, Lei
    Hu, Hao
    Besuyen, Robin
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs: Results from the FINCH 2 Study
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Lee, I-Heng
    Hendrikx, Thijs
    Boonen, Annelies
    Alten, Rieke
    Combe, Bernard
    Walker, David
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, AND HEALTH-RELATED QUALITY OF LIFE, AND REDUCED FATIGUE OVER TIME IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE METHOTREXATE-NAIVE: RESULTS FROM THE FINCH 3 STUDY
    Alten, R.
    Rigby, W.
    Pechonkina, A.
    Yin, Z.
    Hasegawa, K.
    Hendrikx, T.
    Atsumi, T.
    Westhovens, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 634 - 635
  • [7] Filgotinib Provided Rapid and Sustained Improvements in Functional Status, Pain, and Health Related Quality of Life, and Reduced Fatigue over Time in Patients with Rheumatoid Arthritis Who Are Methotrexate-Naive: Results from a Phase 3 Study
    Alten, Rieke
    Rigby, William F. C.
    Pechonkina, Alena
    Yin, Zhaoyu
    Hasegawa, Ken
    Hendrikx, Thijs
    Atsumi, Tatsuya
    Westhovens, Rene
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results from FINCH-1 Study
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Hu, Hao
    Hendrikx, Thijs
    Boonen, Annelies
    Walker, David
    Alten, Rieke
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] A Subgroup Analysis of Clinical Efficacy Response and Quality of Life Outcomes from Phase 3 Study of Filgotinib in Patients with Inadequate Response to Biologic DMARDs
    Genovese, Mark
    de Vlam, Kurt
    Gottenberg, Jacques-Eric
    Bartok, Beatrix
    Tiamiyu, Iyabode
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Walker, David
    Takeuchi, Tsutomu
    Kalunian, Kenneth
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Filgotinib Provided Rapid and Sustained Improvements of Work Productivity and Activity in Patients With Rheumatoid Arthritis who are Methotrexate-naive: Results from the FINCH-3 Study
    Pope, Janet
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Hasegawa, Ken
    Hendrikx, Thijs
    Boonen, Annelies
    Combe, Bernard
    Walker, David
    Alten, Rieke
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1172 - 1173
12345